NIPRO CORPORATION Logo

NIPRO CORPORATION

Global manufacturer of renal care devices, injectable drugs, and pharmaceutical packaging.

8086 | T

Overview

Corporate Details

ISIN(s):
JP3673600007
LEI:
Country:
Japan
Address:
摂津市千里丘新町3番26号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Nipro Corporation is a global, comprehensive healthcare manufacturer founded in 1954. The company operates across four primary business segments: Medical Devices, Pharmaceuticals, Pharma Packaging, and Regenerative Medicine. Nipro is a market leader in renal care, providing a wide range of products for hemodialysis, including dialyzers and blood tubing. Its medical device portfolio also encompasses catheters, infusion kits, and blood collection tubes. The pharmaceuticals division specializes in the contract manufacturing of injectable drugs, while the pharma packaging business produces glass products such as vials and ampoules. Nipro focuses on developing unique technologies and products through its research and development sites to serve the needs of frontline medical treatment worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 02:30
Registration Form
発行登録書(株券、社債券等)
Japanese 29.3 KB
2025-11-14 02:30
Registration Form
確認書
Japanese 8.8 KB
2025-11-14 02:30
Interim / Quarterly Report
半期報告書-第73期(2025/04/01-2026/03/31)
Japanese 305.7 KB
2025-07-18 03:47
Prospectus
発行登録追補書類(株券、社債券等)
Japanese 125.7 KB
2025-07-03 03:01
Registration Form
訂正発行登録書
Japanese 9.7 KB
2025-07-03 03:00
AGM Information
臨時報告書
Japanese 36.5 KB
2025-06-27 02:50
Regulatory Filings
訂正発行登録書
Japanese 80.2 KB
2025-06-25 07:25
Governance Information
内部統制報告書-第72期(2024/04/01-2025/03/31)
Japanese 24.8 KB
2025-06-25 07:24
Registration Form
確認書
Japanese 8.7 KB
2025-06-25 07:24
Annual Report
有価証券報告書-第72期(2024/04/01-2025/03/31)
Japanese 1.8 MB
2025-03-25 07:31
Registration Form
訂正発行登録書
Japanese 9.7 KB
2025-03-25 07:30
Board/Management Information
臨時報告書
Japanese 23.8 KB
2025-03-21 07:31
Registration Form
訂正発行登録書
Japanese 9.7 KB
2025-03-21 07:30
Regulatory Filings
臨時報告書
Japanese 19.2 KB
2025-03-03 02:28
Regulatory Filings
訂正発行登録書
Japanese 9.8 KB

Automate Your Workflow. Get a real-time feed of all NIPRO CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NIPRO CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NIPRO CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea
214370
Caribou Biosciences, Inc. Logo
Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.
United States of America
CRBU
Carisma Therapeutics Inc. Logo
Developing engineered macrophage (CAR-M) therapies for solid tumors and autoimmune diseases.
United States of America
CARM
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572
Cartesian Therapeutics, Inc. Logo
Pioneering mRNA-engineered cell therapies to treat autoimmune diseases.
United States of America
RNAC
CASI Pharmaceuticals, Inc. Logo
Develops and commercializes drugs for oncology, transplant, and autoimmune disease.
United States of America
CASI
CATALYST PHARMACEUTICALS, INC. Logo
Advancing therapies for rare neuromuscular and neurological diseases like LEMS.
United States of America
CPRX
cbdMD, Inc. Logo
Produces & distributes lab-tested CBD wellness products for people and pets.
United States of America
YCBD
CDT Equity Inc. Logo
Clinical-stage biopharma using AI to enhance and advance therapies for unmet medical needs.
United States of America
CDT

Talk to a Data Expert

Have a question? We'll get back to you promptly.